A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2006
12/07/2006	US20060276385 Anti-inflammatory agents and methods of their use
12/07/2006	US20060276382 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders
12/07/2006	US20060276376 Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration
12/07/2006	US20060276375 Gpi anchored glycoprotein aca as a novel tumor marker
12/07/2006	US20060275903 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/07/2006	US20060275764 Method for determining predisposition to manifestation of immune system related diseases
12/07/2006	US20060275759 Neuronally expressed tryptophane hydroxylase and its use
12/07/2006	US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/07/2006	US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase
12/07/2006	US20060275748 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
12/07/2006	US20060275371 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
12/07/2006	US20060275330 Pygopus in diagnosis and treatment of cancer
12/07/2006	US20060275316 Modulation of cxcr4 and related methods and compositions
12/07/2006	US20060275312 Molecule
12/07/2006	US20060275303 Modulating angiogenesis using LL-37/HCAP-18
12/07/2006	US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
12/07/2006	US20060275287 Scroll compressor
12/07/2006	US20060275275 Cells and methods for estimation of effects on neurological dysfunction
12/07/2006	US20060275274 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/07/2006	US20060275267 Nucleic acids encoding inactive variants of human telomerase
12/07/2006	US20060275266 Tripeptide of FcyRIIA
12/07/2006	US20060275265 SiRNA sequence in the form of a plasmid or an AAV vector; nasal inhalation formulation; vaccine against influenza viruses A, B or C and avian influenza (H5N1)
12/07/2006	US20060275264 Using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited; neurodegenerative diseases, Alzheimer's and Parkinson's disease; antiepileptic agents; drug delivery
12/07/2006	US20060275263 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
12/07/2006	US20060275262 Conditionally replicating viruses and methods for cancer virotherapy
12/07/2006	US20060275261 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer
12/07/2006	US20060275258 Interferon-alpha induced gene
12/07/2006	DE102005024836A1 Composition for treatment and prevention of bone tumors and metastases to bone, comprises microorganisms that carry a gene for abnormal bone sialoprotein, inducing an immune response
12/07/2006	CA2611056A1 Method of targeted gene delivery using viral vectors
12/07/2006	CA2610786A1 High affinity melan-a t cell receptors
12/07/2006	CA2610702A1 Targeting cells with altered microrna expression
12/07/2006	CA2609234A1 Anti-il2 antibodies
12/07/2006	CA2609032A1 Method for producing a nucleic-acid-containing complex preparation
12/06/2006	EP1728865A1 Treatment of cervical cancer
12/06/2006	EP1728863A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency
12/06/2006	EP1728532A1 Method and system for myocardial infarction repair
12/06/2006	EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
12/06/2006	EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/06/2006	EP1727560A2 Gastrointestinal proliferative factor and uses thereof
12/06/2006	EP1727556A2 Materials and methods for treatment of inflammatory and cell proliferation disorders
12/06/2006	EP1727546A2 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
12/06/2006	EP1629106A4 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS
12/06/2006	EP1608755A4 Tak1-mediated inhibition of osteogenesis
12/06/2006	EP1590038A4 Light probe for ultraviolet light activated gene transduction
12/06/2006	EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen
12/06/2006	EP1117685B1 Treatment of inflammatory disease
12/06/2006	EP1007686B1 Tuberculosis vaccine
12/06/2006	EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells
12/06/2006	EP0837934B1 Human vascular endothelial growth factor 2
12/06/2006	CN1875107A Vectors
12/06/2006	CN1873013A Recombinant adenoviral vector and methods of use
12/06/2006	CN1873012A New technique for producing carrier of recombined gland related virus ú¿rAAVú®on a large scale
12/06/2006	CN1873008A Gene promoters
12/06/2006	CN1872997A New technique for culturing stem cells (carrying therapy gene) of human's xenogenic stromata in large-scale
12/06/2006	CN1872994A 感染性克隆 Infectious clone
12/06/2006	CN1872347A Cell preparation capable of excreting chalone of endothelium, and application for preparing medicine for treating tumour
12/06/2006	CN1872346A Vaccine for diabetes in type I, and constructing method
12/06/2006	CN1872345A Gene synthetic approach for treating tumor (cancer)
12/06/2006	CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma
12/06/2006	CN1872336A Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
12/06/2006	CN1287862C Method for MG 7-Ag analogue epitope to construct stomack cancer specific poly epitope gene vaccine
12/06/2006	CN1287861C Human source gene guide sequence, gene carrier and gene expression method
12/06/2006	CN1287858C Foot-and-mouth disease gene engineering polypeptide vaccine and its preparing method
12/06/2006	CN1287770C Pharmaceutical compositions in particulate form
12/05/2006	US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
12/05/2006	US7144870 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
12/05/2006	US7144869 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes
12/05/2006	US7144729 Skin disorders; wound healing agents; antiscarring agents
12/05/2006	US7144579 for producing the vectors and suppressing replication/reducing cytotoxicity of vector genome
12/05/2006	US7144575 Methods for selectively stimulating proliferation of T cells
11/2006
11/30/2006	WO2006128084A2 Trps1-mediated modulation of hair growth
11/30/2006	WO2006128041A2 Compositions and methods for the treatment or prevention of chemoresistant neoplasia
11/30/2006	WO2006127976A2 Compositions and their uses directed to ptpru
11/30/2006	WO2006127452A2 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
11/30/2006	WO2006126706A1 Prophylactic/therapeutic agent for psychotic disorder such as bipolar mood disorder and schizophrenia, screening method for the same, and method for determination of risk for the development of the disease
11/30/2006	WO2006126600A1 Pharmaceutical composition for vascular occlusive disease
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006126267A1 Gene transfer method
11/30/2006	WO2006126244A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	WO2006125983A1 Compositions for inducing an immune response against hepatitis b
11/30/2006	WO2006125914A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections
11/30/2006	WO2006125381A1 Tumor targeting gene-virus zd55-il-24, construction method and application thereof
11/30/2006	WO2006125322A1 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
11/30/2006	WO2006125321A1 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
11/30/2006	WO2006047799A3 Treatment of heart failure with csf-1
11/30/2006	WO2005089287A3 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/30/2006	WO2005001042A8 Smooth muscle progenitor cells
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060270623 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
11/30/2006	US20060270622 Article of manufacture and method for disease treatment
11/30/2006	US20060270621 Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
11/30/2006	US20060270620 Method of Enhancing Therapeutic Effect of Nucleic Acids
11/30/2006	US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs
11/30/2006	US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006	US20060270594 Methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein; for treating a lung tumor in a subject by administering a c-met antagonist
11/30/2006	US20060270042 High-titer retroviral packaging cells
11/30/2006	US20060270016 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269924 Modulation of telomere-initiated cell signaling
11/30/2006	US20060269919 Method of diagnosis of obesity

1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 870